Materials • Major Chemicals
$140.58 ▲ +1.90
(+1.37%)
MKT CAP: $18.98B • VOL: 683.1K
52W L $100 52W H $158
DD // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.85B | $6.72B | $6.61B |
| YoY Revenue Growth % | +1.9% | +1.6% | — |
| Gross Profit | $2.36B | $2.22B | $2.91B |
| Gross Margin % | 34.5% | 33.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $103.8M | $829.5M | $499.1M |
| Operating Margin % | 1.5% | 12.3% | 7.5% |
| Net Income (GAAP) | $88.0M | $703.0M | $423.0M |
| EBITDA (Normalized) | $350.4M | $1.07B | $737.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $98.6M | $787.4M | $473.8M |
| Capital Expenditures (CapEx) | $308.2M | $302.4M | $297.6M |
| Free Cash Flow (FCF) | -$209.6M | $485.0M | $176.1M |
| FCF Margin % | -3.1% | 7.2% | 2.7% |
| Return on Invested Capital (ROIC %) | 0.5% | 2.4% | 6.3% |
| Cash & Short-Term Equivalents | $715.0M | $1.79B | $1.15B |
| Total Debt (Short + Long Term) | $3.36B | $5.78B | $2.44B |
| Total Stockholders' Equity | $13.92B | $23.35B | $5.01B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR DD.